Company
LON:ARIX
Arix Bioscience is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences. The company collaborates with exceptional entrepreneurs and provide the capital, expertise and global networks needed to help accelerate their ideas into important new treatments for patients. As a listed company, it aims to bring this growth phase of the industry to a broader range of investors.
180 stories · page 5 of 9
Investments and investor services
The net asset value, which is closely monitored by the market, was £270mln, or £2 a share, a rise of 48p from a year ago. The stock closed Wednesday at 144p
Archive
IGas and Gulf Keystone are on the agenda, meanwhile Brexit will likely be a talking point for Eddie Stobart Logistics.
Updated data from the ongoing AMELIA Phase I/II study showed that all six patients treated at the highest dose achieved minimal residual disease negative complete responses
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Aside from the fizzy drinks firms, the Day Ahead will also bring updates from plumbing and heating products supplier Ferguson and North West Water firm United Utilities
Archive
Aside from the latest instalment of the Brexit saga, the week ahead will bring updates from housebuilder Bellway, tobacco firm Imperial Brands, and soft drinks group Fevertree
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at the day's major movers, including AssetCo, Restore, Miton, Maintel, Microsaic, Footasylum, TomCo, GoldStone and Bluebird
The health and life science investor said the sum would give it a 10% stake in the company and expand the breadth of its portfolio
Investments and investor services
Bercow says the government can only bring back the vote if there has been substantial 'change' to the Brexit deal
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Executive chairman Jonathan Peacock will stay in role, but in a non-executive capacity
Investments and investor services
The UK's blue chip benchmark closed down around 40 points at 7,179, while FTSE 250 shed around 58 at 19,068
Investments and investor services
A look at the day's major movers, including Sabien technology, Stock Spirits, Simigon,UK Oil & Gas, Tungsten, WANdisco, Restaurant Group and Titon
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Hardware & electrical equipment
Harpoon is well-positioned to play a significant role in immuno-oncology, Arix said
Archive
FTSE 100 closed up just over six points at 7,197, while FTSE 250 shed over 74 at 18,898
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at the day's major movers, including Pressure Technologies, 7digital, Hardide, GLI Finance, Modern Water and Mporium
